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Quinolones   Resistance And R-Plasmids Of Clinical Isolates Of Pseudomonas 
Species 
Daini O A1, Effiong MJ 2, Ogbolu OD3. 
ABSTRACT 
Background: There has been reported incidence in the emergence of 
Quinolones resistance in clinical isolates in Nigeria and the level in 
resistance has been on the increase. 
Objective: To determine the antimicrobial resistance patterns and 
plasmids profiles of 67 clinical Pseudomonas species from a teaching 
hospital and diagnostic laboratory in Nigeria. 
Materials and methods: The Pseudomonas species were identified and confirmed by standard 
procedures. The antibiotic susceptibility patterns were determined by Agar Disk Diffusion method. 
Plasmids DNA was isolated, separated and stained as previously described.  
Results: 30 of these clinical isolates were found to be resistant to 6 quinolones antibiotics with 
ciprofloxacin being the highest [52.24%] and norfloxacin [38.81%] the lowest. All the strains that 
were resistant to any antimicrobial agents were also resistant to ciprofloxacin. A total of 54 
plasmids ranging in molecular sizes from 3.55kb to 19.95kb were extracted from the resistant 
strains and grouped into 5 plasmid profiles. Transformation experiment revealed that 66.67% of the 
resistant strains carried a common R plasmid of size 15.85kb. Plasmid –mediated resistant to 
ciprofloxacin and levofloxacin were found. 
Conclusion: The results highlighted diverse plasmids profile and wide spread antimicrobial 
resistance patterns of some clinical Pseudomonas species from Nigeria. 
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seudomonadaceae   as a family are 
highly resistant to antibiotics1-3.  The  
level of  resistance has been on the  
increase and treatment using  the  older  drugs  
are  gradually  failing4. Fluoroquinolones  are  
the newest  effective  antimicrobial  agents  
just  being  introduced  into Nigeria  by  some  
Pharmaceutical   companies under   different 
trade names. These  quinolones  are  used  for  
various  diseases   ranging  from  urinary tract 
infections,  enteric   infections,   septic  
wound, septicaemia etc. 
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Quinolone  resistance  is  increasing in 
clinical  isolates  and  has  reached a 
minimum  inhibitory  concentration(MIC)  in  
Esecherichia coli  at 265mg\ ml  for  
ciprofloxacin5,6. 
Multiple  antibiotic  resistance  in bacteria is  
most commonly  associated  with the  
presence  of  plasmids  which  contain  one or 
more  resistance  genes, each  encoding a 
single antibiotic resistance phenotype7-9.  
Reported  incidence  of  emergence  of  
resistance  to  the  quinolones  by Oni et al10 
and Ozumba11has  prompted this present 
study. Thus, this paper describes the 
antimicrobial susceptibility testing and 
Plasmid screening  of Pseudomonas  species  
isolated  from  clinical specimens in Lagos  
University  Teaching Hospital, Lagos  and 
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METHODOLOGY 
Bacteriology 
Sixty-seven     strains  of  Pseudomonas 
species  isolated   by Standard   procedures12  
from 710 clinical  specimens    sent to the  
diagnostic   laboratory  of Medical  
Microbiology  and Parasitology   laboratory  
of Lagos  University  Teaching  Hospital, 
Lagos and Pathfinder  Diagnostic  Laboratory, 
Lagos, respectively  from  January to 
December 2006. 
Antimicrobial Susceptibility Testing 
Antimicrobial  disc  susceptibility  tests   were   
carried    out on the isolates using  Stokes  
disc  diffusion  technique13 on freshly 
prepared  Muller- Hinton  agar  ( Oxoid, 
England)  and  Standardized  by  the  method 
of National  Committee  for  Clinical  
Laboratory  Standard14,  using the following 
antibiotic   discs; Pefloxacin [Pef] 5µg,  
Ciprofloxacin [Cip] 5µg, Ofloxacin  [Ofx] 
5µg, Levofloxacin [Luv] 5µg, Norfloxacin 
[Nfn] 5µg, and  Sparfloxacin [Spn] 5µg.   
Pseudomonas (NCTC 10662) obtained from 
Central Public   Health Laboratory, London, 
was used as control. Plates with  antibiotic 
discs were incubated for  24hours  at  37 c and 
sensitivity  pattern  was  compared with  that  
of the  control  organism.  
 
 
Isolation  And  Separation of  Plasmid 
DNA 
Plasmid DNA was isolated, separated and 
stained as previously described15.  Plasmid  
profile groups were constructed by  grouping  
strains  possessing the      same profile 
(containing the  same  number and  molecular  
mass), or  part  of a profile  constituting one 
plasmid group. 
Genetic   Transfer 
Transformation was done as described by 
Hanahan16 using Escherichia coli K-12, 
HB101 (ara-14, galk2, hsd520, lacyl, leu, 
mt101, proA2, recA13,  rps120, supE44, thi 
xyl-5) as recipient and plasmid pBR322 as the 
positive  control. Co-transformation of 
resistant character was determined by testing 
all transformants   against all    antibiotics to 
which the donor strains was resistant, 
Extracts from transformants were obtained as 
described above and subjected to Agarose 
electrophoresis. Transformation   was 
confirmed as positive only when  
Resistant transformants were shown to 
contain a plasmid (s) of a size similar to that 
found in the original isolate. 
 
Plasmid Curing: 
The curing of the resistant plasmids of the 
clinical Pseudomonas isolates was done as 
described by Vivyan et al17. 
RESULTS 
The   sources of the clinical Pseudomonas 
isolates are shown in Table 1. 
The isolates were from various body sites. Of  
the  67  clinical Pseudomonas  strains  
isolated,  30  were  resistant to  most  of the  
antimicrobial  agents  tested. 
The frequency of susceptibility to Norfloxacin 
was the highest (61.19%), while the 
sensitivity to other fluoroquinolones was 
shown in Table 2.  A total of 54 different 
plasmids with molecular mass ranging from 
3.55kb to 19.95kb were observed in the 
antibiotic resistant strains. Plasmids were not 
detected in 10 of the resistant strains 
indicating that their resistance was probably 
chromosomally borne. Five  different  
plasmid  profile  groups  for  the  antibiotic  
resistant  strains  could be  defined.  The 
number of strain per plasmid profile group 
vary from 4-6 (Table3). 
The most common antimicrobial resistance 
pattern   was Luv, Pef, Nfn, Spn, Cip, Ofx.  
This  was  followed  in  decreasing  order  of  
occurrence  by the R-types         resistant  
patterns: Luv, Pef, Cip, Spn, Ofx;  Luv; Pef; 
Luv,Pef; Pef, Nfn; Luv, Cip, Nfn; and  Luv, 
Nfn, Spn, Cip, Ofx, harboured  the highest 
number of plasmids, while no plasmid  was  
found in the  strains with  these   resistance  
patterns  viz Luv, Nfn, Spn, Cip, Ofx  and 
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 N n N n N N 
Wound swab 197 22 32 7 229 29 
Urine 82 5 69 2 151 7 
Sputum 42 5 29 3 71 8 
Ear swab 25 3 17 4 42 7 
Throat swab 10 - 16 1 26 1 
Catheter 6 1            - 6 1 
Aspirate 7 1             - 7 1 
Semen 39 1 17 - 56 1 
Urethral 
Discharge 
14 1 14 1 28 2 
Eye swab 25 2 3 - 28 2 
High vaginal 
swab 
40 5 26 3 66 8 
TOTAL 487 46 223 21 710 67 
 
 
KEY: N = Total  Number  of Clinical  specimens, n = Total   Number  of Pseudomonas   species, 





Table 2: Antibiotic sensitivity pattern of clinical isolates of Pseudomonas  
 
 
Antibiotics Number  sensitive %  sensitive %  resistant 
 
Levofloxacin 33 49.25 50.75 
Pefloxacin 38 56.72 43.28 
Ciprofloxacin 32 47.76 52.24 
Norfloxacin 41 61.19 38.81 
Ofloxacin 37 55.22 44.78 
Sparfloxacin 39 58.21 41.79 
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TABLE 3: Plasmid Profile Groups of Antibiotic   Resistant Clinical Pseudomonas Strains 
 
Plasmid Profile No  Of Strains Molecular Mass(Kb) Of 
Plasmids 
0 10 NO     Plasmids 
1 6 3.55, 3.98, 15.85 
2 4 3.55, 3.98, 4.47, 15.85 
3 6 3.55,3.98, 4.47, 15.85, 17.78, 
19.95 






Transformation  experiment  showed  that  
66.67%  of  the  resistant  strains  that  
harboured  plasmids  were  able  to  transfer  
their  resistance  plasmids  to  E.coli K-12 
HB101.  Plasmid- determined resistance to 
ciprofloxacin and levofloxacin was found.  It  
is  noteworthy  that  all  the  R-plasmids  
isolated in this  study  have  a common  
molecular  size  of 15.85kb  (Table 5).  All  
the  strains  harbouring  R-plasmids  were  
cured  of  their  plasmids  upon  treatment  
with  sodium  dodecyl  sulphate (SDS)  with  
resultant  loss  of  their  plasmid-associated  
properties.  This  indicates      that  the  
antibiotic  resistant  genes  of the  
Pseudomonas  strains      used  in  this  study  










No  Of  Isolates          % No With Plasmids 
Luv, Pef,Nfn,Spn,Cip,Ofx 15 50 12 
Luv,Nfn,Spn,Cip, Ofx 1 3.3 NIL 
Luv,Pef, Cip,Spn,Ofx 4 13.3 1 
Luv,Cip,Nfn 1 3.3 NIL 
Pef, Nfn 2 6.7 1 
Luv, Pef 2 6.7 1 
Pef 2 6.7 2 




KEY: Luv= Levofloxacin, Pef = Pefloxacin, Nfn = Norfloxacin, Spn = Sparfloxacin,  
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Transferred To E.Coli 
Hb101 
Transformant R- 
Plasmid Size (Kb) 
35 3.55,3.98,15.85 Cip,  Luv 15.85 
24 3.55,3.98,15.85,19.95 Cip, Luv 15.85 
38 3.55, 3.98, 4.47 15.85 Cip, Luv 15.85 
32 3.55, 3.98, 15.85 Cip,Luv 15.85 
45 3.98,   15.85 Cip, Luv 15.85 
41 3.98, 4.47, 15.85 
19.95 
Cip,Luv 15.85 
42 3.55, 3.98, 15.85 Cip ,Luv 15.85 
17 3.98,  15.85 Cip, Luv 15.85 
28 3.55,  15.85 Cip, Luv 15.85 
33 3.98, 14.47,5.01,15.85 Cip, Luv 15.85 
30 3.98, 4.47,15.85 Cip,Luv 15.85 
14 3.55, 3.98, 15.85 Cip, Luv 15.85 
15 15.85 Luv 15.85 
6 15.85 Luv 15.85 
12 15.85 Cip, Luv 15.85 
39 15.85 Cip, Luv 15.85 
43 3.55, 3.98, 15.85 Cip, Luv 15.85 
20 3.98, 4.47 ,15.85 Cip, Luv 15.85 
5 3.98, 4.47, 15.85 Cip, Luv 15.85 
31 3.98, 15.85,17.78, 
19.95 
Cip, Luv 15.85 
 
KEY: Cip = Ciprofloxacin, Luv = Levofloxacin 
 
Discussion 
In  this  study, most of the Pseudomonas  
aeruginosa were  isolated  from  surgical  
wound  infections (12.66%),  
sputum(11.27%), and urinary   specimen  
 
(4.64%).  This is consistent with earlier 
findings18 for the three sites, and Daini et al.1 
as regards wound infection.  Pseudomonas 
aeruginosa is a well – known      community 
acquired wound infections even in immuno 
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competent patients and are multi- resistant to 
commonly used antimicrobial agents19,20. The 
comparative disc sensitivities shown in 
Table2 is similar to that obtained by the 
author and others1,11.  The  increasing 
resistance of  Pseudomonas  strains to  
fluoroquinolones [table2] is in  agreement 
with  previous  studies8,10,21.  
The antimicrobial resistance pattern revealed 
a total of eight patterns. This indicates the 
emergence of resistance to the   quinolones in 
our environment. Also these patterns depict 
the occurrence of   multi-resistant strains. 
This is similar to that obtained by Odugbemi 
et al8,22,23. All the strains that were resistant to 
any antimicrobial   agents were also resistant 
to ciprofloxacin.  Resistance to high levels of 
antibiotics has been ascribed in most 
instances to the presence of plasmids12,24,25. 
The most common plasmids encountered 
were 15.85kb in size.  This is slightly higher 
than that reported in the litarture1,26.66.67%  
of the   drug  resistant   strains  carried  R-
plasmids. Plasmid determined resistance to 
ciprofloxacin and levofloxacin was found. 
The  emergence  of  R-plasmids  in this   
study  could  be due  to  over zealous  desire  
to  treat  every  infection,  diagnosed  or  
undiagnosed  and  to  the  over  the  counter  
availability of antibiotics4,27,28. A different 
plasmid  profile could be seen  for each of  the  
20 R-plasmids  ,and  plasmids  of  the same  
molecular  could  be  found  in  different  
strains. Thus the plasmid profile of these   
strains was diverse in nature.  Plasmid  
profiling  analysis  distinguished  more  
strains  than  the  antimicrobial  susceptibility  
patterns in agreement with  the   findings  
elsewhere8,29. Plasmid  profiling  has  been  
shown to  be  a  good  epidemiological  tool  
in  investigating  epidemics or out breaks of 
bacterial diseases25,30,31. The   transformation  
experiment  enabled  us  to  detect  non-self  
transmissible plasmids  while  curing of the  
resistant  strains  of the R-plasmids  with  
SDS  showed  that  their  antimicrobial – 
resistant  genes  were  plasmid  borne6,31 8,9.   
Conclusion: 
The  results  of  our  study  highlighted  
diverse  plasmid  profiles  and   widespread   
antimicrobial resistance patterns of some  
clinical  Pseudomonas  species  from  Nigeria  
and we hope  that  this  information  from  
this  locality  would  be a useful base line  for  
further epidemiological studies.  
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